Industry News | tctmd.com

News Industry News

Gore Reacts to RESPECT Trial Results

October 26, 2012

News Industry News

8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

October 25, 2012

News Industry News

Reported at TCT 2012: InspireMD MGuard Stent Meets Primary Endpoint of MASTER Trial, Significantly Improving Prospects of Heart Attack Survival

October 24, 2012

News Industry News

CardioKinetix Initiates Landmark Study of First-of-Its-Kind Treatment for

January 07, 2013

News Industry News

Volcano Announces Global Launch of PrimeWire Prestige® PLUS Pressure Guide Wire with AcuSense™ Technology

October 23, 2012

News Industry News

Cook Medical’s Zilver® PTX® Earns FDA Approval As First Drug-Eluting Stent in U.S. to Treat Peripheral Arterial Disease

November 14, 2012

News Industry News

FDA Approves GORE® Septal Occluder for Use in Gore REDUCE Clinical Study

October 22, 2012

News Industry News

Neovasc's Tiara™ transcatheter mitral valve selected as a best new device concept at TCT 2012 Scientific Symposium

October 23, 2012

News Industry News

Medtronic Completes First-In-Man Study for Investigational Next-Generation Multi-Electrode Renal Denervation System in Patients with Treatment-Resistant Hypertension

October 03, 2012

News Industry News

Eurocor’s DEBIFU Registry successfully enrolled first patients

September 24, 2012

Subscribe to Industry News

Advertisement

Gore Reacts to RESPECT Trial Results

8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

Reported at TCT 2012: InspireMD MGuard Stent Meets Primary Endpoint of MASTER Trial, Significantly Improving Prospects of Heart Attack Survival

CardioKinetix Initiates Landmark Study of First-of-Its-Kind Treatment for

Volcano Announces Global Launch of PrimeWire Prestige® PLUS Pressure Guide Wire with AcuSense™ Technology

Cook Medical’s Zilver® PTX® Earns FDA Approval As First Drug-Eluting Stent in U.S. to Treat Peripheral Arterial Disease

FDA Approves GORE® Septal Occluder for Use in Gore REDUCE Clinical Study

Neovasc's Tiara™ transcatheter mitral valve selected as a best new device concept at TCT 2012 Scientific Symposium

Medtronic Completes First-In-Man Study for Investigational Next-Generation Multi-Electrode Renal Denervation System in Patients with Treatment-Resistant Hypertension

Eurocor’s DEBIFU Registry successfully enrolled first patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content